Hepatitis C virus pharmacogenomics in Latin American populations: implications in the era of direct-acting antivirals.
about
Hepatitis C virus pharmacogenomics in Latin American populations: implications in the era of direct-acting antivirals.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 28 March 2017
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Hepatitis C virus pharmacogeno ...... a of direct-acting antivirals.
@en
Hepatitis C virus pharmacogeno ...... a of direct-acting antivirals.
@nl
type
label
Hepatitis C virus pharmacogeno ...... a of direct-acting antivirals.
@en
Hepatitis C virus pharmacogeno ...... a of direct-acting antivirals.
@nl
prefLabel
Hepatitis C virus pharmacogeno ...... a of direct-acting antivirals.
@en
Hepatitis C virus pharmacogeno ...... a of direct-acting antivirals.
@nl
P2093
P2860
P356
P1476
Hepatitis C virus pharmacogeno ...... a of direct-acting antivirals.
@en
P2093
Daniel Corach
Diego Flichman
Julieta Trinks
Mariela Caputo
María L Hulaniuk
P2860
P356
10.2147/PGPM.S125452
P577
2017-03-28T00:00:00Z